Joinder Agreements in the Biotechnology Industry
11 Contracts & Agreements
- AgeX Therapeutics, Inc. (2 contracts)
- Chanticleer Holdings, Inc. (1)
- LianBio (1)
- ORAGENICS INC (1)
- ORGANOVO HOLDINGS, INC. (2)
- SEATTLE GENETICS INC (1)
- Solid Biosciences Inc. (1)
- Synthetic Biologics, Inc. (1)
- VistaGen Therapeutics, Inc. (1)
- Joinder Agreement, dated November 9, 2023, between Reverse Bioengineering, Inc., ReCyte Therapeutics, Inc., UniverXome Bioengineering, Inc., AgeX Therapeutics, Inc. and... (AgeX Therapeutics, Inc., Filed With SEC on November 14, 2023)
- Joinder Agreement, dated November 9, 2023, between Reverse Bioengineering, Inc., ReCyte Therapeutics, Inc., UniverXome Bioengineering, Inc., AgeX Therapeutics, Inc. and... (AgeX Therapeutics, Inc., Filed With SEC on November 14, 2023)
- Form of Support and Joinder Agreement (Solid Biosciences Inc., Filed With SEC on September 30, 2022)
- Joinder Agreements to Second Amended and Restated Shareholders Agreement (LianBio, Filed With SEC on October 20, 2021)
- Joinder to Assignment of Oral Mucositis SIA by and between Oragenics, Inc. and Intrexon Corporation between Oragenics, Inc. and Intrexon Corporation, effective January 1, 2018 (ORAGENICS INC, Filed With SEC on February 16, 2018)
- Assignment,Assumption, Joinder AND AMENDMENT Agreement JFFranchise Systems, LLC (Chanticleer Holdings, Inc., Filed With SEC on December 12, 2013)
- JOINDER AGREEMENT (Synthetic Biologics, Inc., Filed With SEC on October 31, 2012)
- JOINDER AGREEMENT (ORGANOVO HOLDINGS, INC., Filed With SEC on March 19, 2012)
- JOINDER AGREEMENT (ORGANOVO HOLDINGS, INC., Filed With SEC on March 19, 2012)
- JOINDER AGREEMENT (VistaGen Therapeutics, Inc., Filed With SEC on May 16, 2011)
- JOINDER AGREEMENT (SEATTLE GENETICS INC, Filed With SEC on May 15, 2003)
